Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to test the safety and efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (UCMSC) for the treatment of Systemic Sclerosis (SSc).


Clinical Trial Description

A single-center, three-arm, randomized, double-blind, placebo-controlled trial is proposed. A total of 18 SSc patients will be enrolled in 3 successive blocks of 6 patients each. After being informed about the study and potential risks, all patients giving written informed consent will be randomized to one of two treatment arms or a placebo arm (total of 6 patients per arm). Within each block, the 6 patients will be randomized in a 2:2:2 ratio in one of the following arms: placebo, 1 infusion of UCMSC (M0), or 2 infusions of UCMSC (M0, M3). Second infusions of UCMSC will be performed only in the absence of Treatment Related Severe Adverse Events (TRSAE). Randomization into blocks 2 and 3 will be staggered, to allow the detection of TRSAE prior to inclusion of patients in a subsequent block, i.e. the second block will be randomized only in the absence of TRSAE one month after the first infusion of all 6 patients in block one, and similarly for the third block. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04356287
Study type Interventional
Source Sir Mortimer B. Davis - Jewish General Hospital
Contact Marie Hudson, MD
Phone 514-340-8222
Email marie.hudson@mcgill.ca
Status Recruiting
Phase Phase 1/Phase 2
Start date January 5, 2023
Completion date December 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01221428 - Umbilical Cord Mesenchymal Stem Cells Infusion for Ulcerative Colitis Phase 1/Phase 2
Active, not recruiting NCT01219465 - Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus Phase 1/Phase 2
Completed NCT03105284 - Adipose-tissue Derived Stem Cells in Flaps Versus Liposuction N/A
Not yet recruiting NCT01224327 - Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients Phase 1/Phase 2
Recruiting NCT06149832 - Treatment of Oral Chronic Graft-versus-host Disease With Human Umbilical Cord Mesenchymal Stem Cell Dressing Phase 4
Recruiting NCT05165459 - Open Label Single Arm Proof of Concept Trial to Evaluate the Efficacy and Safety of Cytori Celution System in Chronic Non-Healing Venous Leg Ulcers N/A
Active, not recruiting NCT04014166 - Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia N/A
Not yet recruiting NCT06077734 - Muscle Stem Cell Quality in Atrophy
Completed NCT00956891 - Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation Phase 1/Phase 2
Recruiting NCT01218464 - Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure Phase 1/Phase 2
Active, not recruiting NCT03874572 - Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth Phase 1
Recruiting NCT00953485 - Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS) Phase 1/Phase 2
Not yet recruiting NCT04863183 - Cell Therapy With Cellistem-OA for Symptomatic Knee Osteoarthritis Phase 1/Phase 2
Completed NCT06360861 - Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1
Completed NCT05018754 - Treatment of Oral Mucositis Using Platelet Rich Fibrin TREATMENT OF ORAL MUCOSITIS USING PRF
Completed NCT03130374 - Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells Phase 1/Phase 2
Active, not recruiting NCT02673788 - Follow-Up Study of Safety of Pneumostem® in Premature Infants With Intraventricular Hemorrhage
Recruiting NCT01763086 - Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant Phase 2
Recruiting NCT01763099 - Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure Phase 2
Completed NCT02302599 - Mesenchymal Stem Cells to Treat Type 2 Diabetes Phase 2